Breaking News
FONT-SIZE Plus   Neg
Share SHARE

CVC Capital Partners, ValueAct Continue To Consider Options In Respect Of Misys

Funds advised by CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. noted the recent announcement by Vista of its recommended cash offer for Misys Plc (MSY.L, MUSJF.PK).

Misys had announced today that it agreed to be acquired by an investment vehicle owned by US-based private equity firm Vista Equity Partners for 350 pence per share, totaling about 1.3 billion pounds.

CVC and ValueAct continue to consider their options in respect of Misys, including a possible recommended joint cash offer for the company and urge Misys shareholders to take no action at this time.

However, there can be no certainty that an offer will be made by CVC and ValueAct, nor, if made, that a deal will result.

Click here to receive FREE breaking news email alerts for Misys plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The Swiss National Bank on Thursday reaffirmed its currency ceiling and interest rate unchanged, as expected by economists, and expressed willingness to do more to defend the franc. The central bank maintained the minimum exchange rate of CHF 1.20 per euro and left the target range for the three-month Libor unchanged at 0.0-0.25 percent. The South Korean government said Thursday it will increase the budget spending next year and run a wider fiscal deficit than expected to bolster economic growth that faces challenges from slow global recovery and weak domestic demand. Government spending will rise by 5.7 percent to KRW 376 trillion the next year, the finance ministry said in its budget proposals. Stocks saw some volatility following the release of the Federal Reserve's monetary policy announcement on Wednesday but managed to end the day modestly higher. With the upward move, the Dow reached a new record closing high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.